Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Qiying Fang"'
Autor:
Boxi Chen, Qiying Fang, Yiming Tao, Siqi Peng, Shuting Deng, Ye Yuan, Nan Jiang, Sichun Wen, Bohou Li, Qiong Wu, Zewen Zhao, Pingjiang Ge, Sijia Li, Ting Lin, Zhonglin Feng, Feng Wen, Lei Fu, Zhuo Li, Jia Wen, Renwei Huang, Chaosheng He, Wenjian Wang, Guibao Ke, Lixia Xu, Shuangxin Liu, Jianchao Ma
Publikováno v:
Renal Failure, Vol 46, Iss 2 (2024)
Background Secondary hyperparathyroidism (SHPT) is a prevalent chronic complication in patients undergoing hemodialysis. Parathyroidectomy (PTX) is crucial for reducing mortality and improving the prognosis in the treatment of refractory hyperparathy
Externí odkaz:
https://doaj.org/article/01672a80300e4c74baca228874aa659c
Publikováno v:
Artificial Organs
Hypercytokines cause acute respiratory distress syndrome (ARDS) in coronavirus disease 2019 (COVID-19) patients, which is the main reason for intensive care unit treatment and the leading cause of death in COVID-19 patients. Cytokine storm is a criti
Autor:
Qiying Fang1 jjb763@163.com, Xinghua Zhao2
Publikováno v:
Tropical Journal of Pharmaceutical Research. Apr2017, Vol. 16 Issue 4, p925-930. 6p.
Publikováno v:
Molecular Immunology. 46:2178-2182
Serum anti-C1q antibodies are associated with disease activity in patients with lupus nephritis. Recent studies showed that anti-C1q antibodies recognize both the collagen region and the globular head regions (gC1q) of individual A (ghA), B (ghB), an
Publikováno v:
Human Immunology. 69:840-844
Serum levels of C-reactive protein (CRP) often remain low despite high disease activity in systemic lupus erythematosus (SLE). Sera from 96 patients with renal biopsy-proven active lupus nephritis, 24 of 96 patients in remission, and 49 patients with
Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis
Publikováno v:
Nephrology Dialysis Transplantation. 24:172-178
UNLABELLED Objective. Anti-C1q antibodies are common in sera from patients with lupus nephritis (LN) and are associated with disease activity. The current study aimed to further investigate the prevalence of serum IgG anti-C1q antibody, its subclass